S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
CVE:CXV

BLVD Centers Co. (CXV.V) Stock Forecast, Price & News

C$0.07
+0.07 (+∞)
(As of 06/25/2018)
Add
Compare
Today's Range
C$0.06
Now: C$0.07
C$0.07
50-Day Range
C$0.07
MA: C$0.07
C$0.07
52-Week Range
C$0.05
Now: C$0.07
C$0.18
Volume1.59 million shs
Average Volume1.10 million shs
Market CapitalizationC$16.28 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
BLVD Centers Corporation provides detoxification and outpatient rehabilitation services. It operates rehabilitation centers under the BLVD Centers brand name in Los Angeles, Orange County, Corona, and San Diego, California; and Portland, Oregon. The company was formerly known as Convalo Health International, Corp. and changed its name to BLVD Centers Corporation in June 2017. BLVD Centers Corporation was incorporated in 2013 and is headquartered in Los Angeles, California.

MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market CapC$16.28 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.07
+0.07 (+∞)
(As of 06/25/2018)
30 days | 90 days | 365 days | Advanced Chart

Receive CXV News and Ratings via Email

Sign-up to receive the latest news and ratings for CXV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BLVD Centers Co. (CXV.V) (CVE:CXV) Frequently Asked Questions

What stocks does MarketBeat like better than BLVD Centers Co. (CXV.V)?

Wall Street analysts have given BLVD Centers Co. (CXV.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BLVD Centers Co. (CXV.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of BLVD Centers Co. (CXV.V)'s key competitors?

What other stocks do shareholders of BLVD Centers Co. (CXV.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BLVD Centers Co. (CXV.V) investors own include Nextech Ar Solutions (NTAR), Bellatrix Exploration (BXE) and Beleave (BE).

Who are BLVD Centers Co. (CXV.V)'s key executives?

BLVD Centers Co. (CXV.V)'s management team includes the following people:
  • Mr. Chris Heath, CEO & Exec. Director
  • Mr. Pablo Mendez, Interim CFO & VP of Accounting (Age 49)
  • Mr. Jason C, Chief Operations Officer
  • Mr. Robert Grossman, Corp. Sec. (Age 44)
  • Mr. Edward Brann, Corp. Advisor

What is BLVD Centers Co. (CXV.V)'s stock symbol?

BLVD Centers Co. (CXV.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CXV."

How do I buy shares of BLVD Centers Co. (CXV.V)?

Shares of CXV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is BLVD Centers Co. (CXV.V)'s stock price today?

One share of CXV stock can currently be purchased for approximately C$0.07.

How big of a company is BLVD Centers Co. (CXV.V)?

BLVD Centers Co. (CXV.V) has a market capitalization of C$16.28 million.

What is BLVD Centers Co. (CXV.V)'s official website?

The official website for BLVD Centers Co. (CXV.V) is www.convalohealth.com.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.